Slots: Starting in 2024, ADA will accept up to two (2) nominations per institution with one (1) nomination spanning basic through preclinical research and one (1) nomination spanning clinical through public health research.
Each nomination can be for either of the Pathway Program Award types: Initiator or Accelerator. Please be aware that if an institution nominates two (2) applicants with proposed projects covering the same phase of research (i.e. basic through preclinical research studies), one of the submitted applications will be administratively disqualified from consideration for funding.
Deadlines
Internal Deadline: Friday, May 17th, 2024, 5pm PT TBA
LOI: N/A
External Deadline: Estimated mid-July 2025
Award Information
Award Type: Grant
Anticipated Award Amount: Up to $100,000 year in Phase 1, up to $325,000/year in Phase 2. Awards provide two distinct phases of research support: Phase 1 provides up to two years of support for mentored training at a maximum of $100,000 per year (including 10% indirect costs), Phase 2 provides up to five years of support for independent research at a maximum of $325,000 per year (including 30% indirect costs). Maximum combined support for Phase 1 and Phase 2 is $1,625,000.
Who May Serve as Applicant: Eligible applicants must currently be in research training positions (post-doctoral fellow, research fellowship) and have no more than seven years of research training following terminal doctoral degree. Applicants cannot concurrently hold an NIH K99/R00 grant. Candidates must be identified through institutional nomination; applications will be accepted only from individuals with the appropriate institution support.
Candidate’s appointment at the Sponsoring Institution must be full-time. Rare exceptions to full-time positions may be granted on a case-by-case basis and must be pre-approved by Pathway administration staff prior to application submission.
Applicants must hold a MD, PhD, DMD, DO, PharmD, DVM or an equivalent health- or science-related degree.
Applicant fellowship positions must be at university-affiliated institutions or other non-profit research institutions within the United States and U.S. possessions.
Individuals must have permission to work within the U.S., either as U.S. citizens or permanent residents, or with appropriate work visas/permits. Institutional confirmation of permission to work within the U.S. will be required at the time of application submission.
Recipients of Initiator Awards cannot concurrently hold an NIH K99/R00 grant. All other Career Development awards are allowable (unless holding of concurrent awards is prohibited by the other granting agency).
One person must be specified as the PI; co-PIs are not permitted.
If funded, the Principal Investigator must agree to devote at least 75% of their total time and overall
effort towards research. This percentage includes time dedicated to the Association-funded grant in
addition to grants supported by other funding agencies. Please note that during the award’s duration,
the Principal Investigator must commit between 25-50% effort towards the Association funded project
An appropriate institutional representative responsible for the final approval of the nomination
submission (Dean of Research, Nominating Committee Chair, Division Chair, etc.) must submit a
Letter of Nomination on behalf of the institution, co-signed by the nominee’s Division or Department
Head, delineating the institution’s nomination and commitment to the applicant.
Link to Award: https://professional.diabetes.org/research-grants/current-funding-opportunities-pathway-stop-diabetes
Process for Limited Submissions
PIs must submit their application as a Limited Submission through the Research Initiatives and Infrastructure (RII) Application Portal: https://rii.usc.edu/oor-portal/. Use the template provided here: RII Limited Submission Applicant Template
Materials to submit include:
- (1) Two-Page Proposal Summary (1” margins; single-spaced; standard font type, e.g. Arial, Helvetica, Times New Roman, or Georgia typeface; font size: 11 pt). Page limit includes references and illustrations. Pages that exceed the 2-page limit will be excluded from review. You must use the template linked above.
- (2) CV – (5 pages maximum)
Note: The portal requires information about the PIs in addition to department and contact information, including the 10-digit USC ID#, Gender, and Ethnicity. Please have this material prepared before beginning this application.
Purpose
The Pathway Initiator award is designed to support early career researchers who have distinguished themselves during their research training as exceptionally talented and promising research investigators with a high likelihood of establishing successful, independent research programs and making seminal contributions in diabetes research. These awards are highly competitive and intended to support particularly innovative and transformational ideas that have the potential to have an exceptional impact in diabetes with an emphasis on the investigator’s potential to significantly transform diabetes through translational research (‘moving the needle’) to improve the lives of people with diabetes. These awards provide salary and research support for applicants during late stages of mentored training through establishment as independent research faculty.
Visit our Institutionally Limited Submission webpage for more updates and other announcements.